Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Abu Jazara Husam
High-Dose Therapy and Autologous Hematopoietic Progenitor Cells Transplantation for Relapsed or Refractory Hodgkin Lymphoma: A Follow Up Analysis of King Hussein Cancer Center,results and Prognostic Variables
Trends in Transplantation
Related publications
Brentuximab Vedotin Salvage Followed by Consolidation Post Autologous Hematopoietic Stem Cell Transplantation in High Risk Relapsed Refractory Hodgkin Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Timing of Salvage Therapy and Autologous Hematopoietic Cell Transplant in Relapsed Hodgkin and Non Hodgkin Lymphoma
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
A Phase I Trial of 19-28z Car-T Cells Post-High Dose Therapy and Autologous Transplantation (Hdt-Asct) for Relapsed and Refractory (R/R) B-Cell Non-Hodgkin Lymphoma (B-Nhl)
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Prognostic Value of Pretransplant FDG-PET in Refractory/Relapsed Hodgkin Lymphoma Treated With Autologous Stem Cell Transplantation: Systematic Review and Meta-Analysis
Annals of Hematology
Medicine
Hematology
Nivolumab for Relapsed/Refractory Classical Hodgkin Lymphoma After Autologous Transplant: Full Results After Extended Follow-Up of the Phase 2 Checkmate 205 Trial
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Prognostic Factors and Long-Term Outcome of Autologous Haematopoietic Stem Cell Transplantation Following a Uniform-Modified BEAM-conditioning Regimen for Patients With Refractory or Relapsed Hodgkin Lymphoma: A Single-Center Experience
Medical Oncology
Medicine
Cancer Research
Oncology
Hematology
Haploidentical Hematopoietic Stem Cell Transplantation Compared With Hla-Matched Stem Cell Transplantation for Refractory or Relapsed Aggressive Non-Hodgkin Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
High-Dose Chemotherapy (HDC) and Autologous Hematopoietic Stem Cell Transplantation (ASCT) as Salvage Therapy for Relapsed Osteosarcoma
Bone Marrow Transplantation
Transplantation
Hematology
Relapsed and Refractory Nodular Lymphocyte-Predominant Hodgkin Lymphoma (Nlphl): A Us Analysis From Md Anderson Cancer Center
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology